Literature DB >> 8778160

Early occurrence of a thyroid carcinoma in a patient who developed Graves' disease after treatment for Hodgkin's disease.

A Belfiore1, G Pellegriti, G Milone, G Vigneri, P Gangemi, A Fiumara, R Vigneri.   

Abstract

We report the case of a patient who developed Graves' disease and a papillary thyroid cancer only 5 years after irradiation and adjuvant chemotherapy for Hodgkin's disease. This case is peculiar for the very short latency time between Hodgkin's disease treatment and thyroid cancer development, an event possibly related to Graves' disease with elevated serum levels of TSAb. We conclude that, in patients treated for Hodgkin's disease, continued follow-up by clinical examination and sonography of the thyroid is needed, especially if they develop Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8778160     DOI: 10.1007/BF03349835

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

Review 1.  Thyroid cancer and Graves' disease.

Authors:  E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1990-04       Impact factor: 5.958

2.  The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer.

Authors:  S Filetti; A Belfiore; S M Amir; G H Daniels; O Ippolito; R Vigneri; S H Ingbar
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

3.  Risk of second cancers after treatment for Hodgkin's disease.

Authors:  M A Tucker; C N Coleman; R S Cox; A Varghese; S A Rosenberg
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

Review 4.  Molecular basis of thyroid cancer.

Authors:  N R Farid; Y Shi; M Zou
Journal:  Endocr Rev       Date:  1994-04       Impact factor: 19.871

5.  Thyroid abnormalities following neck irradiation for Hodgkin's disease.

Authors:  D F Nelson; K V Reddy; R E O'Mara; P Rubin
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

Review 6.  Increased aggressiveness of thyroid cancer in patients with Graves' disease.

Authors:  A Belfiore; M R Garofalo; D Giuffrida; F Runello; S Filetti; A Fiumara; O Ippolito; R Vigneri
Journal:  J Clin Endocrinol Metab       Date:  1990-04       Impact factor: 5.958

7.  Thyroid carcinoma in Graves' disease.

Authors:  L M Farbota; D B Calandra; A M Lawrence; E Paloyan
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

8.  Thyroid diseases after treatment of Hodgkin's disease.

Authors:  S L Hancock; R S Cox; I R McDougall
Journal:  N Engl J Med       Date:  1991-08-29       Impact factor: 91.245

9.  Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.

Authors:  I B Hales; A McElduff; P Crummer; P Clifton-Bligh; L Delbridge; R Hoschl; A Poole; T S Reeve; E Wilmshurst; J Wiseman
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

10.  Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

Authors:  J M Kaldor; N E Day; P Band; N W Choi; E A Clarke; M P Coleman; M Hakama; M Koch; F Langmark; F E Neal
Journal:  Int J Cancer       Date:  1987-05-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.